K-Ensol Co., Ltd. (KOSDAQ:053080)
13,670
0.00 (0.00%)
At close: Feb 19, 2026
K-Ensol Revenue
K-Ensol had revenue of 123.36B KRW in the quarter ending September 30, 2025, a decrease of -24.37%. This brings the company's revenue in the last twelve months to 506.57B, down -12.32% year-over-year. In the year 2024, K-Ensol had annual revenue of 579.20B with 38.75% growth.
Revenue (ttm)
506.57B
Revenue Growth
-12.32%
P/S Ratio
0.35
Revenue / Employee
2.77B
Employees
183
Market Cap
177.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 579.20B | 161.76B | 38.75% |
| Dec 31, 2023 | 417.44B | 28.63B | 7.36% |
| Dec 31, 2022 | 388.81B | 77.71B | 24.98% |
| Dec 31, 2021 | 311.10B | -15.80B | -4.83% |
| Dec 31, 2020 | 326.90B | 98.51B | 43.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Multicampus | 336.47B |
| TOPTEC | 214.82B |
| Keeps Biopharma | 157.75B |
| YTN Co.,Ltd. | 150.70B |
| LS THiRA-UTECH | 55.95B |
| Codes Combine | 38.71B |
| BIOBIJOU | 33.71B |
| Autocrypt | 25.78B |